“Can I combine this with that?” is one of the questions that comes up the most in any peptide community — and the one giant matrix-style tables tend to answer the worst, since finding your exact combination is harder than the question itself. That's why we built Stack Compatibility: you pick two compounds and get back a single verdict, not 500 cells.
In short: The tool answers one concrete question (A + B, yes or no?) with 4 possible statuses — studied, caution, avoid, or no data — always pulled from what each peptide profile already states, never a guess. When there's no data, we say “no data” instead of making up a verdict.
How it works
You pick two compounds from the list and the tool instantly shows one of these four statuses. No verdict is invented to fill a gap — if the combination doesn't show up in any source, the result is honest: “no data,” not a fabricated green or red light.
Studied
The source itself (one or both peptide profiles) explicitly names that combination — for example, the “GLOW” recovery blend (BPC-157 + GHK-Cu + TB-500) or the classic GHRH + GHRP synergy.
Caution
The mechanisms don't conflict with each other, but there's no formal study of that specific combination either — just category-level plausibility (for example, a GLP-1 alongside a recovery peptide: completely different mechanisms, no known conflict, but no trial of the actual mix).
Avoid
There's a concrete reason not to combine them — almost always because they're two compounds from the same family doing the same job (two GHRPs, two GHRH analogs, two GLP-1/GIP agonists at once), which doesn't add effect, just redundancy.
No data
The combination doesn't show up in any source we use. That doesn't mean it's forbidden or that the app is broken — it literally means we couldn't find anything published about that specific mix. We'd rather say that than invent a verdict that looks more complete.
The most-checked combos
| Combo | Estado | Nota |
|---|---|---|
| BPC-157 + TB-500 | Studied | The classic recovery combo — the most reported one in the whole community. |
| Ipamorelin + CJC-1295 | Studied | Classic GHRH + GHRP combo — the most reported one in this category. |
| Selank + Semax | Studied | Classic nootropic combo: calm (Selank) + focus (Semax). |
| Semaglutide + BPC-157 | Caution | Different mechanisms (metabolic vs. tissue repair) — no known conflict, but no formal study of this specific combination either. |
| Semaglutide + Tirzepatide | Avoid | Combining two GLP-1/GIP agonists at once isn't recommended. |
| Ipamorelin + GHRP-2 | Avoid | Combining two GHRPs at once isn't recommended. |
These are just 6 examples to illustrate the 4 statuses — the tool covers quite a few more combinations across recovery/skin, GLP-1, growth peptides (GHRH/GHRP), and nootropics. Try it directly with your own combination in the tool.
How to get the most out of it
- Check every compound in your stack pairwise, not just the newest one you're about to add. If you're already on 3 peptides, there are 3 combinations to check, not just the newcomer's.
- “No data” isn't a green light or a red light — it's a signal that this specific combination has no literature behind it, and it's worth a conversation with your doctor before assuming it's safe by default.
- An “avoid” is almost always redundancy, not extreme danger — it usually means both compounds do the same job, so combining them doesn't multiply the effect, just the cost.
- Keep your full protocol in one place so you can recheck every pair when you add a new compound, instead of trying to remember what you were already taking.
If you're already running several peptides at once, PeptiBrain lets you keep your whole stack logged — doses, vials, and protocol — so you can check it against the compatibility tool every time you add something new.
